- Home
- HRZN vs BNTC Comparison
HRZN vs BNTC Comparison
Compare HRZN & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRZN
- BNTC
- Stock Information
- Founded
- HRZN 2008
- BNTC 1995
- Country
- HRZN United States
- BNTC United States
- Employees
- HRZN N/A
- BNTC N/A
- Industry
- HRZN Finance/Investors Services
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- HRZN Finance
- BNTC Health Care
- Exchange
- HRZN Nasdaq
- BNTC Nasdaq
- Market Cap
- HRZN 324.5M
- BNTC 335.5M
- IPO Year
- HRZN 2010
- BNTC N/A
- Fundamental
- Price
- HRZN $7.74
- BNTC $11.65
- Analyst Decision
- HRZN Hold
- BNTC Strong Buy
- Analyst Count
- HRZN 4
- BNTC 5
- Target Price
- HRZN $9.19
- BNTC $26.00
- AVG Volume (30 Days)
- HRZN 491.2K
- BNTC 72.5K
- Earning Date
- HRZN 08-07-2025
- BNTC 09-25-2025
- Dividend Yield
- HRZN 17.05%
- BNTC N/A
- EPS Growth
- HRZN N/A
- BNTC N/A
- EPS
- HRZN N/A
- BNTC N/A
- Revenue
- HRZN $98,302,000.00
- BNTC N/A
- Revenue This Year
- HRZN $1.42
- BNTC N/A
- Revenue Next Year
- HRZN $4.42
- BNTC N/A
- P/E Ratio
- HRZN N/A
- BNTC N/A
- Revenue Growth
- HRZN N/A
- BNTC N/A
- 52 Week Low
- HRZN $7.09
- BNTC $7.69
- 52 Week High
- HRZN $11.47
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- HRZN 45.72
- BNTC 45.75
- Support Level
- HRZN $7.40
- BNTC $10.53
- Resistance Level
- HRZN $7.93
- BNTC $11.74
- Average True Range (ATR)
- HRZN 0.22
- BNTC 0.69
- MACD
- HRZN -0.09
- BNTC 0.11
- Stochastic Oscillator
- HRZN 32.08
- BNTC 64.84
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.